A Phase 1 dose-escalation study of the safety and pharmacokinetics of once-daily oral foretinib, a multi-kinase inhibitor, in patients with solid tumors. (Q54478410)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase 1 dose-escalation study of the safety and pharmacokinetics of once-daily oral foretinib, a multi-kinase inhibitor, in patients with solid tumors. |
scientific article |
Statements
A Phase 1 dose-escalation study of the safety and pharmacokinetics of once-daily oral foretinib, a multi-kinase inhibitor, in patients with solid tumors. (English)
1 reference
Geoffrey I Shapiro
1 reference
Laurel M Adams
1 reference
Laurie Sherman
1 reference
Steve Weller
1 reference
Suzanne Swann
1 reference
Harold Keer
1 reference
Dale Miles
1 reference
Thomas Müller
1 reference
Patricia Lorusso
1 reference
6 October 2012
1 reference
31
1 reference
742-750
1 reference
3
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference